Best practice guidelines Buccal (Oromucosal) midazolam
This document is intended to serve as a guideline for those purchasing as well as delivering training in the administration of Buccal midazolam. It is hoped the guideline will provide assistance to the local regulatory authority and to help establish a national standard of minimal training.
The information on this page is for Healthcare Professionals’ use only. Please do not share with patients and/or their carers.
ADVERSE EVENTS SHOULD BE REPORTED
Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/.
Adverse events should also be reported to Neuraxpharm UK Ltd by:
- Email: pv-uk@neuraxpharm.com
- Phone number: +44 330 128 0919
